Summary & Overview
HCPCS C9248: Clevidipine Butyrate Injection, 1 mg
HCPCS Level II code C9248 denotes a 1 mg unit of clevidipine butyrate injectable formulation, an intravenous, ultra-short-acting dihydropyridine calcium-channel blocker used for rapid control of blood pressure in acute care settings. This code is significant nationally as it standardizes billing for a high-acuity, titratable antihypertensive used during surgery, in intensive care, and in other monitored environments where precise hemodynamic control is required. Payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find a concise review of clinical context for clevidipine use, the service setting and administration considerations tied to C9248, and what to expect from payer coverage patterns and billing practices at a national level. The publication presents benchmarks for utilization and reimbursement where available, summarizes relevant policy and coding updates, and highlights common billing modifiers and service-line considerations. Data not available in the input will be noted when applicable, and the focus remains on clarifying what C9248 represents and how it maps to clinical and billing workflows across major payers.
Billing Code Overview
HCPCS Level II code C9248 represents Injection, clevidipine butyrate, 1 mg. The service type is intravenous antihypertensive medication administration, typically provided in acute inpatient or monitored procedural settings such as operating rooms, intensive care units, or post-anesthesia care units where rapid blood-pressure control is required.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with severe, acute postoperative hypertension in the post-anesthesia care unit following cardiac surgery requires rapid, titratable intravenous antihypertensive therapy. The anesthesiology team orders continuous infusion of clevidipine butyrate with intermittent vial-level documentation of administered milligrams. Pharmacy compounds and dispenses clevidipine in the operating room or intensive care unit per institutional protocol; nursing initiates the infusion via an infusion pump and titrates to target systolic blood pressure. Dosing is recorded as milligram equivalents using the billing descriptor C9248 (Injection, clevidipine butyrate, 1 mg) for each milligram administered or dispensed. Typical workflow steps include medication order entry, pharmacy verification and preparation under aseptic technique, bedside administration with infusion pump settings, blood pressure monitoring, documentation of dose and time, and eventual wean or discontinuation when hemodynamics stabilize. Common contexts include intraoperative blood pressure control, immediate postoperative hypertension, or acute hypertensive emergencies in monitored settings where rapid on/off control of vascular tone is required. Typical site of service is the hospital inpatient setting — operating room, post-anesthesia care unit, or intensive care unit — where continuous intravenous vasodilator infusions and close hemodynamic monitoring are available.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 |